Should You Hold Crinetics Pharmaceuticals (CRNX)? - Yahoo Finance
3 days ago • Google News
Crinetics Pharmaceuticals Inc (CRNX)
US$ 39.383.04%
Price Chart
Key Statistics
Market Cap
$ 2.99B
P/E Ratio
0.00
Revenue (TTM)
$ 760K
Volume
879.62K
52W High
$ 62.53
52W Low
$ 24.10
Dividend Yield
0.00%
Beta
0.28
Technicals
50-Day MA
31.166
200-Day MA
41.4082
52 Week High
62.53
52 Week Low
24.1
About CRNX
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-r.
Employees
437
Headquarters
San Diego, CA
CEO
Dr. R. Scott Struthers Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg